Improving health outcomes for people with opioid and tobacco use disorders
Official title: Mentoring investigators to improve health outcomes among persons with opioid and tobacco use disorder
Funded at Albert Einstein College of Medicine · NIH-11060946 · Data updated 2026-11-12
This study is all about finding better ways to help people who are dealing with opioid and tobacco addiction, while also training new researchers from diverse backgrounds to make sure their work really helps those in need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | April 1, 2022 |
| Project end | March 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $194,400 |
| NIH project number | 5K24DA051807-04 |
| Project ID | NIH-11060946 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with opioid and tobacco use disorders, particularly those from underrepresented communities.
✕Less likely to help
Patients who do not have substance use disorders or those who are not seeking treatment may not benefit from this research.
What this research studies
This research focuses on enhancing the delivery of evidence-based treatments for individuals struggling with opioid and tobacco use disorders. It aims to train the next generation of researchers in patient-oriented addictions research, particularly those from underrepresented racial and ethnic backgrounds. The approach includes mentoring early-career investigators and developing innovative methods to optimize treatment interventions. By involving stakeholders, the research seeks to ensure that the findings are applicable in real-world settings, ultimately improving access to care for those in need.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and increased access to effective treatments for individuals with substance use disorders.
How similar studies have gone: Previous research has shown success in improving treatment access and outcomes for substance use disorders through targeted mentoring and community engagement.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Nahvi, Shadi — Albert Einstein College of Medicine
- Study coordinator: Nahvi, Shadi
Related research
Other NIH-funded projects on the same topics.
-
VR-based attentional bias as a biomarker for tobacco use disorder
A study at UC San Diego is testing a virtual reality task to see if attentional bias can serve as a biomarker to help treat cigarette addiction.
-
Community health worker support to help people with serious mental illness quit smoking
This project trains Medicaid behavioral health staff to act as community health workers who help adults with serious mental illness stop using tobacco.
-
Smoking-cessation meds with a team approach for people with HIV (SMARTTT)
A multi-site study tests a team-based plan using medication and rewards to help people with HIV quit smoking.
-
Using virtual reality to understand how attention affects tobacco addiction
This study is looking at how daily tobacco users react to virtual reality situations that remind them of smoking, to see if their attention to these cues can help predict how well they might do with quitting smoking, especially when using a medication called varenicline compared to a placebo.
-
A program to help individuals with bipolar disorder reduce tobacco use through future thinking.
This study is testing a new program called 'Future Self-BD' to help people with bipolar disorder who want to quit smoking by imagining positive future outcomes from stopping, and it aims to see how well the program works and if it's easy to use.
-
Using focused ultrasound to help people quit smoking
This study is looking at a new, gentle ultrasound treatment that might help people who want to quit smoking by reducing their cravings for cigarettes, and it's designed for anyone struggling with tobacco use.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.